The Journal of the Korea Contents Association (한국콘텐츠학회논문지)

The Korea Contents Association (한국콘텐츠학회)
권호 표지
DOI QR코드

DOI QR Code

Influences of Health-related Factors on Uterine Myoma

건강 관련 요인이 자궁근종에 미치는 영향

  • 최지현 (한서대학교 방사선학과) ;
  • 김정구 (한서대학교 방사선학과)
  • Published : 2010.01.28
Download PDF
⟨ Previous Next ⟩

Abstract

Prevalence of female uterine myoma was determined using ultrasound diagnosis instrument, and correlation between health-related factors and uterine myoma was analyzed to investigate concrete factors for production of uterine myoma. Subjects in uterine myoma group and control group were asked to answer the questionnaire survey. The results were determined that prevalence of uterine mayma was 29.7%, and 40~49 aged group showed the highest level of uterine myoma by 41.4%. (p<0.05). The analysis showed that there were significant correlations between uterine myoma and collected variables such as age, marital status, occupational activity level, satisfaction level of life, weight, obesity, delivery history, breast feeding, abortion, and contraceptive experience (p<0.05).

여성의 자궁근종에 대한 유병률을 초음파진단장비로 확인하고 건강 관련 요인과 자궁근종과의 상관관계를 분석하여 건강 관련 요인이 자궁근종의 발생에 미치는 구체적인 발생 요인을 확인하고자 한다. 자궁근종이 진단된 모집단과 자궁근종이 없는 대조군을 대상으로 자가 기입식 설문조사를 실시한 결과 초음파진단 장비로 진단된 자궁근종의 유병률은 29.7%로 나타났으며, 자궁근종군의 연령분포는 40~49세가 41.4%로 가장 높게 나타났다(p<0.05). 자궁근종의 유병률에 영향을 미치는 각 요인에 대하여 조사한 결과, 연령, 결혼력, 직업의 활동량, 생활의 만족도, 체중, 비만도, 분만력, 수유, 유산, 피임 등은 자궁근종과의 상관관계에서 통계적으로 유의하였다.(p<0.05)

Keywords

References

  1. D. T. Baird, T. A. Bramley, and T. A. Hawkins, "Effect of treatment with LHRH analogue Zoladex on binding of oestradiol, Progestrone and epidemal growth factor to Uterine fibromyoma," Horm, Vol.32, No.1, pp.154-156, 1989 https://doi.org/10.1159/000181333
  2. D. D. Brandon, T. E. Erickson, and E. J. Keenan, "Estrogen receptor gene expression in human Uterine leiomyoma," J. Clin. Endocrinol. Metab., Vol.80, No.6, pp.1876-1881, 1995. https://doi.org/10.1210/jc.80.6.1876
  3. V. C. Buttram Jr and R. C. Reiter, "Uterine leiomyoma:Etiology, Symptomatology, and Management," Fertil. Steril., Vol..36, No.4, pp.433-445, 1981. https://doi.org/10.1016/S0015-0282(16)45789-4
  4. G. P. Flake and J. A. Darlene Dixon, "Etiology and pathogenesis of Uterine leiomyomas:A review," Environmental Health Perspectives, Vol.111, No.8, pp.1037-1054, 2003.
  5. F. Paraziini, C. La Vecchia, and E. Negri, "Epidemiologic characteristics of women with uterine fibroids:a case-control study," Obstet Gynecol, Vol.72, No.6, pp.853-857, 1988. https://doi.org/10.1097/00006250-198812000-00008
  6. A. S. Lev-Toaff, B. G. Coleman, P. H. Arger, "Leiomyomas in pregnancy;sonographic study," Radiology, Vol.164, No.2, pp.375-380, 1987. https://doi.org/10.1148/radiology.164.2.3299488
  7. Donna Day Baird, David B. Dunson, Michael C. Hill, "High cumulative incidence of Uterine leiomyoma in black and white women:Ultrasound evidence," AM. J. Obstet. Gynecol., Vol.188, No.1, pp.100-107, 2003. https://doi.org/10.1067/mob.2003.99
  8. F. Chiaffarino, F. Paraziini, C. La Vecchia, "Diet and Uterine myomas," Obstet. Gynecol., Vol.94, No.3, pp.395-398, 1999. https://doi.org/10.1016/S0029-7844(99)00305-1
  9. L. H. Arthur, R. M. Daniel, A. S. Jr. Morton, Comprehensive Gynecology, 2nd ed. St. Louise, Mosby, p.182, 1992.
  10. C. K. Requard, F. A. Mettler, and J. D. Wicks, "Preoperative sonography of malignant ovarian neoplasms," AJR, Vol.137, No.1, pp.79-82, 1981. https://doi.org/10.2214/ajr.137.1.79
  11. 홍대기, 자궁근종 관련인자의 역학적 연구, 경북대학교 대학원 의학과, 2006.
  12. 강은정, 국민건강 영양조사 제3기, 한국보건사회연구원, 2005.
  13. 한국표준직업분류, 통계청, 2000.
  14. 박정규 외 8인, “자궁근종에 관한 임상통계학적 연구”, 대한산부인과학회지, 제48권, 제2호, pp.436-445, 2005.
  15. 황성연 외 3인, “자궁근종의 임상 및 병리학적 연구”, 원광의과학, 13권, 12호, pp.87-96, 1997.
  16. S. A. Shikora, J. M. Niloff, and B. R. Bistrian, "Relationship between obesity and Uterine leiomyoma," Nutrition, Vol.7, No.4, pp.251-255, 1991. https://doi.org/10.1146/annurev.nu.07.070187.001343
  17. F. Sato, M. Nishi, and R. Kudo, "Body fat distribution and Uterine leiomyomas," J. Epidemiol, Vol.8, No.3, pp.176-180, 1998. https://doi.org/10.2188/jea.8.176
  18. L. M. Marshall, D. Spiegelman, and M. B. Goldman, "A prostective study of reproductive factors and oral contraceptive use in relation to the risk of Uterine leiomyoma," Fertil. Steril., Vol.70, No.3, pp.432-439, 1998. https://doi.org/10.1016/S0015-0282(98)00208-8
  19. F. Chiaffarino, F. Paraziini, and C. Vecchia, "Use of oral contraceptive and Uterine fibroids:results from a case-control study," Br. J. Obstet. Gynecol. Vol.106, No.8, pp.857-860, 1999. https://doi.org/10.1111/j.1471-0528.1999.tb08409.x
  20. L. Bernstein, M. C. Pike, and P. K. Ross, "Estrogen and sex hormone-binging globulin levels in nulliparous and parous women," J. Natl. Cancer Inst., Vol.74, No.4, pp.741-745, 1985.
  21. Renee Boynton-Jarrett, Janet Rich-Edwards, and Susan Malspeis, "A Prospective study of Hypertension and Risk of Uterine leiomyoma," AM. J. Epidemiology, Vol.161, No.7, pp.628-638, 2005. https://doi.org/10.1093/aje/kwi072

Cited by

  1. Psychiatric outcomes after hysterectomy in women with uterine myoma: a population-based retrospective cohort study vol.20, pp.4, 2017, https://doi.org/10.1007/s00737-017-0745-6